# Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery

Study · id `cardio:ct-nct02921230` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02921230](<https://clinicaltrials.gov/study/NCT02921230>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02921230

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 775 participants.

## Technical summary

Registry record NCT02921230. Randomized; single masking; primary purpose treatment. Start 2016-10-25 (actual); primary completion 2021-07-02 (actual). Results posted on 2024-10-28.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 775 participants (enrolled count; ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Started: 2016-10-25 (actual) (ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Primary completion: 2021-07-02 (actual) (ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Completion: 2023-11-06 (actual) (ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Results first posted: 2024-10-28 (ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Countries: Austria; Belgium; France; Germany; Ireland; Italy; Netherlands; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT02921230, source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02921230-2025-02-24`, retrieved 2026-10-31)

## The registry's words

- Brief title: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
- Acronym: EMINENT
- Condition: Arterial Occlusive Diseases
- Condition: Atherosclerosis
- Condition: Vascular Diseases
- Condition: Arteriosclerosis
- Intervention (Device): Peripheral stenting
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial (`cardio:pubmed-36254728`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b344887501f4535282d8adc431f7b9e98a68e8190d75e8f35f4417adf2ad62c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
